HIV prevalence and risk behavior among injecting drug users who participate in 'low-threshold' methadone programs in Amsterdam
C. Hartgers,
A.J.A.R. Van den Hoek,
P. Krijnen and
R.A. Coutinho
American Journal of Public Health, 1992, vol. 82, issue 4, 547-551
Abstract:
Introduction. After the onset of the HIV epidemic, the hope arose that the 'harm reduction' approach of the Amsterdam 'low-threshold' methadone programs would have a function in controlling the spread of HIV among injecting drug users (IDUs). Methods. To find evidence for this assumption, 386 IDUs participating in an HIV study between 1985 and 1989 were studied. Long-term regular participants in low-threshold methadone programs were compared with short-term and/or irregular participants. Results. Controlling for possible confounders, long-term regular participants had a slightly increased but not statistically significant risk of being HIV infected. With regard to current drug use, they injected daily and shared needles as often as did short-term and/or irregular participants. Conclusions. The results suggest that the Amsterdam low-threshold methadone programs fail to diminish HIV risk behavior. If these programs want to have a positive effect on the spread of HIV, expansion of existing HIV prevention efforts, an increase in the daily methadone dose level, and measures to enforce regular attendance may be required.
Date: 1992
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:1992:82:4:547-551_0
Access Statistics for this article
American Journal of Public Health is currently edited by Alfredo Morabia
More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().